EVH vs. PYCR, TDC, DOCN, VSH, SVFCX, HAYW, WOLF, USM, AI, and ATHM
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Paycor HCM (PYCR), Teradata (TDC), DigitalOcean (DOCN), Vishay Intertechnology (VSH), Smead Value C (SVFCX), Hayward (HAYW), Wolfspeed (WOLF), United States Cellular (USM), C3.ai (AI), and Autohome (ATHM). These companies are all part of the "computer and technology" sector.
Evolent Health (NYSE:EVH) and Paycor HCM (NASDAQ:PYCR) are both mid-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment.
In the previous week, Paycor HCM had 11 more articles in the media than Evolent Health. MarketBeat recorded 29 mentions for Paycor HCM and 18 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.45 beat Paycor HCM's score of 0.20 indicating that Evolent Health is being referred to more favorably in the media.
Evolent Health presently has a consensus target price of $42.00, indicating a potential upside of 71.71%. Paycor HCM has a consensus target price of $25.25, indicating a potential upside of 74.14%. Given Paycor HCM's higher possible upside, analysts plainly believe Paycor HCM is more favorable than Evolent Health.
36.8% of Paycor HCM shares are held by institutional investors. 3.3% of Evolent Health shares are held by company insiders. Comparatively, 0.4% of Paycor HCM shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Paycor HCM has lower revenue, but higher earnings than Evolent Health. Paycor HCM is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.
Evolent Health received 510 more outperform votes than Paycor HCM when rated by MarketBeat users. Likewise, 73.88% of users gave Evolent Health an outperform vote while only 35.48% of users gave Paycor HCM an outperform vote.
Evolent Health has a net margin of -5.07% compared to Paycor HCM's net margin of -11.11%. Evolent Health's return on equity of 6.84% beat Paycor HCM's return on equity.
Evolent Health has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, Paycor HCM has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500.
Summary
Evolent Health beats Paycor HCM on 12 of the 18 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
